Alternative Data for Boston Scientific
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 1,051 | Sign up | Sign up | Sign up |
| Sentiment | 92 | Sign up | Sign up | Sign up |
| Webpage traffic | 652,000 | Sign up | Sign up | Sign up |
| Employee Rating | 82 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 2,031 | Sign up | Sign up | Sign up |
| Facebook Followers | 79,016 | Sign up | Sign up | Sign up |
| Reddit Mentions | 6 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 25 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 6,681 | Sign up | Sign up | Sign up |
| X Followers | 40,718 | Sign up | Sign up | Sign up |
| X Mentions | 109 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| ESG | N/A | Sign up | Sign up | Sign up |
| Lobbying Cost | $190,000 | Sign up | Sign up | Sign up |
| Business Outlook | 77 | Sign up | Sign up | Sign up |
| Linkedin Employees | 52,265 | Sign up | Sign up | Sign up |
| NPS | 25 | Sign up | Sign up | Sign up |
About Boston Scientific
Boston Scientific Corp is a developer, manufacturer, and marketer of medical devices. The firm markets its devices to health-care professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
| Price | $93.61 |
| Target Price | Sign up |
| Volume | 9,610,000 |
| Market Cap | $137B |
| Year Range | $88.07 - $108.14 |
| Dividend Yield | 0% |
| PE Ratio | 49.47 |
| Analyst Rating | 95% buy |
| Earnings Date | February 4 '26 |
| Industry | Medical Devices |
In the news
 |
PAHC vs. BSX: Which Stock Is the Better Value Option?January 26 - Yahoo |
|
Boston Scientific touts long-term data of SCS therapyJanuary 25 - Yahoo |
|
Is Boston Scientific (BSX) Pricing In Too Much Optimism After Mixed Share Performance?January 23 - Yahoo |
|
Our Boston Scientific Pick Has Stumbled. Acquiring Penumbra Will Help the Stock.January 23 - Yahoo |
|
Boston Scientific (BSX) Exceeds Market Returns: Some Facts to ConsiderJanuary 23 - Yahoo |
|
Oppenheimer Questions $14.5B Penumbra Deal Valuation Despite Boston Scientific’s (BSX) Mew Market DominanceJanuary 22 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 5.07B | 1.52B | 3.54B | 755M | 1.37B | 0.750 |
| Q2 '25 | 5.06B | 1.64B | 3.42B | 793M | 1.37B | 0.750 |
| Q1 '25 | 4.66B | 1.71B | 2.95B | 674M | 1.22B | 0.750 |
| Q4 '24 | 4.56B | 1.89B | 2.67B | 566M | 1.07B | 0.700 |
| Q3 '24 | 4.21B | 1.56B | 2.65B | 469M | 1.06B | 0.630 |
Insider Transactions View All
| Butcher Arthur C filed to sell 23,600 shares at $101.6. December 2 '25 |
| Zane Ellen M filed to sell 24,134 shares at $98.3. November 6 '25 |
| Fitzgerald Joseph Michael filed to sell 224,742 shares at $100.7. November 4 '25 |
| Fitzgerald Joseph Michael filed to sell 178,342 shares at $99.1. November 4 '25 |
| Fitzgerald Joseph Michael filed to sell 207,814 shares at $99.8. November 4 '25 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Gilbert Cisneros |
Jan 13, 26 | Sell | $1K - $15K |
| Gilbert Cisneros |
Dec 16, 25 | Buy | $1K - $15K |
| Gilbert Cisneros |
Nov 19, 25 | Buy | $1K - $15K |
Read more about Boston Scientific (BSX) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
FAQ - Boston Scientific
The Market Cap of Boston Scientific is $137B.
As of today, Boston Scientific's PE (Price to Earnings) ratio is 49.47.
Boston Scientific will report its next earnings on February 4 '26.
Currently, the price of one share of Boston Scientific stock is $93.61.
The BSX stock price chart above provides a comprehensive visual representation of Boston Scientific's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Boston Scientific shares. Our platform offers an up-to-date BSX stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Boston Scientific (BSX) does not offer dividends to its shareholders. Investors interested in Boston Scientific should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Boston Scientific are Edwards Lifesciences, Intuitive Surgical, Medtronic, Stryker, and Becton Dickinson and Co.
